Clinical Trial Update: A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031. [Phase 1]

View source ↗

Summary

A Phase 1 study in Parkinson's disease investigating an increased dose step in patients who previously received placebo or the investigational drug sNN0031 has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• sNN0031

Snippet

Sponsor: Newron Sweden AB | Conditions: Parkinson's Disease | Phase 1 | Status: TERMINATED